Dong-A Socio Holdings Co Ltd - Company Profile
Powered by
All the data and insights you need on Dong-A Socio Holdings Co Ltd in one report.
- Save hours of research time and resources with
our up-to-date Dong-A Socio Holdings Co Ltd Strategy Report
- Understand Dong-A Socio Holdings Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd, a subsidiary of Dong-A Socio Group that offers business management services. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials. The group focuses on new business investments, APIs, OTC products, consumer goods, prescription drugs, development of biomedicines, and research and development of new innovative drugs. Its major products include quasi-drug, Bacchus; a cold medicine, Anti-inflammatory, Antipyretic, Analgesic Drug, namely, Panpyrin-T, Panpyrin Q; Morning Care; a tampon; contraceptive medicine such as Myvlar; among others. Dong-A Socio Holdings is headquartered in Seoul, South Korea.
Dong-A Socio Holdings Co Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Prescription Drugs: | Panpyrin |
Anti-Cancer | Circulan |
Anti-Fungal | Bigen Cream Tone |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | Dong-A Socio Holdings Co Ltd | Bayer Yakuhin Ltd | SeouLin Bioscience Co Ltd | PharmaResearch Bio Co Ltd | Oscotec Inc |
---|---|---|---|---|---|
Headquarters | South Korea | Japan | South Korea | South Korea | South Korea |
City | Seoul | Kita-Ku | Seongnam | Gangneung | Seongnam |
State/Province | - | Osaka | - | - | - |
No. of Employees | 273 | 2,554 | 88 | 78 | 35 |
Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Shin-Ho Kang | Chairman | Executive Board | - | - |
Jae Hun Jung | Chief Executive Officer; Director; Vice President | Executive Board | - | - |
Seung-Hyun Ko | Director - Finance; Chief Financial Officer | Executive Board | 2021 | - |
Min-Woo Jo | Director - Executive | Executive Board | 2023 | - |
Se Won Kwon | Director | Non Executive Board | 2022 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer